Abstract:Background: Organophosphate esters (OPEs) are increasingly used as flame retardants and plasticizers in various products. In vivo and in vitro studies suggest that OPEs can affect metabolic health but the human evidence is lacking. Objectives: We analyzed data from the U.S. National Health and Nutrition Examination Survey, 2011-2014, to examine the associations between urinary OPE metabolites and metabolic syndrome (MetS) and its components in adults. Methods: We included a total of 1157 adults aged ≥20 years who had information on urinary OPE metabolites, components of MetS and essential covariates in the current analyses. MetS was composed of hyperglycemia, hypertension, hypertriglyceridemia, low high-density cholesterol, and central obesity. Binary logistic regression and weighted quantile sum (WQS) regression were used to assess the associations of individual OPE metabolites and OPEs mixture with MetS and its components. All analyses were conducted in men and women separately. Potential effect modification by age, serum total testosterone (TT) level and menopause status were also examined via stratified analyses as well as by testing the significance of the interaction term with exposure. Results: After adjusting for confounders, bis(2-chloroethyl) phosphate (BCEP) and bis(1,3-dichloro-2-propyl) phosphate (BDCPP) were positively associated with MetS in a dose-dependent manner (P-trend = 0.02 and 0.02 for BCEP and BDCPP, respectively) in all men. Meanwhile, increasing quartiles of DPHP was positively associated with hyperglycemia (P-trend = 0.03), but DBUP was inversely associated with central obesity (P-trend = 0.02). WQS analyses in all men found that OPEs mixture (OPEs index) was positively associated with MetS [odds ratio (OR) for OPEs index: 1.65; 95%CI :1.21, 2.24], hyperglycemia (OR:1.47; 95%CI:1.09,2.00), and central obesity (OR:1.36; 95%CI:1.01,1.83). Although there was no significant interaction between exposure and effect modifiers, stratified analyses in men suggested that significant associations were mainly limited to those aged < 60 years or those with TT < 437 ng/dL (the median level in men). By contrast, the associations with MetS and its components were sparse and inconsistent in women except for the positive association between OPEs index and central obesity. Conclusions: In this cross-sectional study, exposure to OPEs was positively associated with elevated odds of MetS and individual components in men, especially among those aged <60 years or those with relatively low TT level. But the associations were less apparent in women except for the consistent positive association of OPEs mixture with central obesity. Nevertheless, these results need to be interpreted with caution and should be confirmed in future studies, ideally with multiple urine samples collected prospectively to improve the exposure measurement of OPEs.

Oxidative Stress Mediates the Association of Organophosphate Flame Retardants with Metabolic Obesity in U.S. Adults: a Combined Epidemiologic and Bioinformatic Study

Exposure to OPFRs Is Associated with Obesity and Dysregulated Serum Lipid Profiles: Data from 2017–2018 NHANES

Association between organophosphate flame retardant exposure and lipid metabolism: data from the 2013–2014 National Health and Nutrition Examination Survey

The Relationship of Organophosphate Flame Retardants with Hyperuricemia and Gout Via the Inflammatory Response: an Integrated Approach.

Exposure to Organophosphate esters and metabolic syndrome in adults

Association between organophosphorus pesticides and obesity among American adults

Gender-specific abdominal fat distribution and insulin resistance associated with organophosphate esters and phthalate metabolites exposure

Gestational exposure to organophosphate ester flame retardants and risk of childhood obesity in the environmental influences on child health outcomes consortium

Mediating Role of Glucose-Lipid Metabolism in the Association between the Increased Risk of Coronary Heart Disease and Exposure to Organophosphate Esters, Phthalates, and Polycyclic Aromatic Hydrocarbons

Maternal exposure to organophosphate flame retardants and neonatal anthropometric measures

Association Between Exposure to a Mixture of Phenols, Pesticides, and Phthalates and Obesity: Comparison of Three Statistical Models.

Association analysis between organophosphorus flame retardants exposure and the risk of depression: Data from NHANES 2017–2018

Association of Co-Exposure to Organophosphate Esters and Per- and Polyfluoroalkyl Substances and Mixture with Cardiovascular-Kidney-liver-metabolic Biomarkers among Chinese Adults

Associations between co-exposure to per- and polyfluoroalkyl substances and metabolic diseases: The mediating roles of inflammation and oxidative stress

Associations between urinary organophosphate ester metabolites and measures of adiposity among U.S. children and adults: NHANES 2013-2014

Urinary Concentrations of Organophosphate Flame-Retardant Metabolites in the US Population

Association Between Organophosphorus Flame Retardants Exposure and Cognitive Impairment among Elderly Population in Southern China.

Organophosphorus Flame Retardants and Their Metabolites in Paired Human Blood and Urine

Sex-Specific Associations Between Organophosphate Esters Metabolites and Metabolic Dysfunction-Associated Fatty Liver Disease in Chinese Adults

Phthalate metabolites and sex steroid hormones in relation to obesity in US adults: NHANES 2013-2016

Associations of Single and Multiple Organophosphate Pesticide Exposure with Female Infertility in the USA: Data from the 2015–2018 National Health and Nutrition Examination Survey